Informace o projektu
Central European Advanced Therapy and Immunotherapy Centre
(CREATIC)
- Kód projektu
- 101059788
- Období řešení
- 9/2023 - 8/2029
- Investor / Programový rámec / typ projektu
-
Evropská unie
- Horizont Evropa
- Rozšiřování účasti a posílení ERA
- Fakulta / Pracoviště MU
-
Lékařská fakulta
- doc. MUDr. Regina Demlová, Ph.D.
- Ing. Ondřej Bar
- Mgr. Tomáš Bárta, Ph.D.
- PharmDr. Adéla Bártová
- Mgr. Petr Bureš
- PharmDr. Zora Čechová, Ph.D.
- Mgr. Barbora Čechovská
- Mgr. Kateřina Černá Pilátová, Ph.D.
- MUDr. Jiří Deml
- Ing. Lucie Flajšarová
- Mgr. Petr Fojtík, Ph.D.
- Mgr. Jakub Gregor, Ph.D.
- doc. MVDr. Aleš Hampl, CSc.
- Ing. Veronika Hlávková
- Mgr. et Mgr. Zuzana Hrabovská
- Mgr. Eva Hrubá, Ph.D.
- Mgr. Jakub Jamárik
- Mgr. Lucie Jurečková
- prof. MUDr. Tomáš Kašpárek, Ph.D.
- MUDr. Tomáš Kepák, Ph.D.
- RNDr. Martin Komenda, Ph.D., MBA
- Mgr. Tomáš Kopecký
- Mgr. Bc. Michal Koščík, Ph.D.
- Ing. Mgr. Alexandra Koutná
- Silvie Koutná
- Mgr. Jana Kubátová, Ph.D.
- MUDr. Michal Kýr, Ph.D.
- Ing. Sofiia Lymarenko
- MUDr. Tomáš Merta
- Mgr. Marie Mlnaříková
- MUDr. Peter Múdry, Ph.D.
- Mgr. Vendula Pelková
- Mgr. Veronika Plachá
- prof. RNDr. Šárka Pospíšilová, Ph.D.
- MUDr. Ondřej Rohleder
- PharmDr. Jiří Samek
- Mgr. Jana Sedláková
- MUDr. Kateřina Slabá
- prof. RNDr. Ondřej Slabý, Ph.D.
- Mgr. Tereza Souralová
- Mgr. Eva Šťastná
- prof. MUDr. Jaroslav Štěrba, Ph.D.
- MUDr. Martin Štěrba
- prof. MUDr. Petr Štourač, Ph.D., MBA, FESAIC
- Mgr. Gabriela Tomaštíková
- MUDr. Terézia Tureková
- prof. MUDr. Dalibor Valík, Ph.D., DABCC
- doc. RNDr. Petr Vaňhara, Ph.D.
- Ing. Eva Veselá
- Mgr. Eliška Vladíková
- Anastasiya Volakhava, M.Sc.
- prof. RNDr. Lenka Zdražilová Dubská, Ph.D.
- WWW stránky projektu
- https://creatic.muni.cz/
- Spolupracující organizace
-
Kobenhavns Universitet
- Odpovědná osoba Jakob Wested
- Odpovědná osoba Maik Friedrich
- Odpovědná osoba Anna Duenkel
Progress in biomedical science enables us to use a whole new toolbox to treat significant groups of diseases, such as inherited rare diseases or diverse rare cancers. Advanced therapy medicinal products (ATMPs) apply recent advances in genomics, cell biology and/or gene editing to deliver truly personalized curative options. The project proposes to establish flagship ATMP-focused facility on the margin of academia and clinics: Central European Advanced Therapy and Immunotherapy Centre (CREATIC) at the Masaryk University (MUNI) in Brno, Czech Republic. MUNI will team up with the leading European research institutions: (1) Fraunhofer Institute for Cell Therapy and Immunology IZI, (2) Leipzig University, which together forms a significant cluster of research excellence in research, development and training in the fields of gene and cell therapies and (3) Copenhagen University with unique expertise in biomedical innovation law, intellectual property, biomedical ethics, privacy and regulatory framework, and health technology assessment. The project will allow for (i) fundamental expansion of the scope of the R&I activities of all partners to build multidisciplinary excellence facilitating the delivery of ATMPs to patients who need them; (ii) establishment of the high level of decision-making autonomy for the CREATIC, which will allow significant organizational and management changes creating spirit and conditions for cutting-edge research and innovation in the Centre, and (iii) strengthen the smart specialization of the Czech Republic (RIS3 CZ 2021-2027) in the domain of Advanced medicine and drugs through the involvement of actors from the academic, public, private and societal sector. Our approach reflects research priorities and societal challenges outlined in the Pharmaceutical Strategy for Europe, which proposes ‘bedside’ manufacture of highly individualised medicines as a future trend in treating rare diseases with ATMPs.
Cíle udržitelného rozvoje
Masarykova univerzita se hlásí k cílům udržitelného rozvoje OSN, jejichž záměrem je do roku 2030 zlepšit podmínky a kvalitu života na naší planetě.
Publikace
Počet publikací: 2
2024
-
Emergency medicine pharmacotherapy compromises accuracy of plasma creatinine determination by enzyme-based methods: real-world clinical evidence and implications for clinical practice
-
Fekální bakterioterapie - metoda, transplantace, nebo podání léčivého přípravku?
Rok: 2024, druh: Konferenční abstrakty